Indian F&O data, and the evidence about what not to trade · educational
CIPLA · Healthcare
1M / 3M / 1Y
-5.7% / +0.1% / -12.2%
Traded value (60d med)
₹135 cr
Days in F&O ban since 2020
0
Futures OI / 1d change
10.7M / -0.0M
ATM implied vol
19% (vs 13% realized)
📜 Results-day history
Typical move 2.4% · up on the day 38% of 26 events · moved 4%+ in 27% · worst -4.0% / best +9.6%
| Reaction day | Move | Open gap | Next 5d | Announced |
|---|
| 2026-07-24 | +1.3% | -0.2% | +4.4% | after close |
| 2026-05-01 | +0.0% | +0.6% | +2.9% | after close |
| 2026-01-23 | -4.0% | +0.1% | +0.7% | during mkt |
| 2025-10-30 | -2.6% | +0.4% | -2.5% | during mkt |
| 2025-07-28 | +2.6% | +0.6% | -3.6% | after close |
| 2025-05-02 | -1.6% | -0.8% | -3.0% | after close |
| 2025-01-29 | +0.2% | +1.4% | +0.9% | during mkt |
| 2024-10-30 | -4.0% | -2.5% | +12.4% | after close |
Educational data reference: NOT investment advice. Historical statistics do not predict future results. We are not SEBI-registered advisers. All data from NSE public sources; figures may contain errors. Trading, especially leveraged F&O, can cause significant losses.